Published 3 days ago • loading... • Updated 3 days agoShow Less IconBiohaven stock downgraded at RBC Capital Markets (BHVN:NYSE) Summary by Seeking AlphaBiohaven (BHVN) stock dips as RBC downgrades the company to Sector Perform, citing its recent licensing deal worth up to $795M with SK Biopharma. Read more here.Share menu1 Articles1 ArticlesAllLeftCenterRight1Search IconSort IconSeeking AlphaLean RightFactualityOwnershipBiohaven stock downgraded at RBC Capital Markets (BHVN:NYSE)Biohaven (BHVN) stock dips as RBC downgrades the company to Sector Perform, citing its recent licensing deal worth up to $795M with SK Biopharma. Read more here.3 days ago·Ra'anana, IsraelRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right1Center0Last Updated3 days agoBias Distribution100% RightBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Right100% RightR 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSeeking Alpha broke the news in Ra'anana, Israel 3 days ago on Tuesday, September 8, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsRoyal Bank of Canada Plus IconStock Markets Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsRoyal Bank of Canada Plus IconStock Markets Plus IconShow All